The validity and reliability of the global index of safety (GIS)

Current Medical Research and Opinion

Volumn 20, Issue 11, 2004, Pages 1825-1832

  Prieto, L ^a   Sacristan J A ^a   Gomez J C ^a  

^a ELI LILLY AND COMPANY   (Spain)

Author keywords

Adverse drug reaction reporting systems; Antipsychotic agents; Consumer product safety; Drug monitoring; Pharmacoepidemiology; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE;

ABDOMINAL PAIN; AGITATION; AGRANULOCYTOSIS; AKATHISIA; AMBLYOPIA; AMENORRHEA; ANOREXIA; ANXIETY DISORDER; APATHY; ARTHROPATHY; ASTHENIA; ATAXIA; BACKACHE; CALIBRATION; CHILL; CONFERENCE PAPER; CONFUSION; CONSTIPATION; CONVULSION; CORRELATION COEFFICIENT; COUGHING; DELIRIUM; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DREAM; DRUG SAFETY; DYSKINESIA; DYSMENORRHEA; DYSPEPSIA; DYSPNEA; DYSTONIA; EDEMA; EJACULATION DISORDER; EUPHORIA; EXTRAPYRAMIDAL SYMPTOM; FEVER; GALACTORRHEA; GASTRITIS; GLOBAL INDEX OF SAFETY; GYNECOMASTIA; HEADACHE; HEART ARRHYTHMIA; HEART PALPITATION; HOSPITAL PATIENT; HOSTILITY; HOT FLUSH; HUMAN; HYPERPROLACTINEMIA; HYPERSALIVATION; HYPERTENSION; HYPOKINESIA; HYPOTENSION; IMPOTENCE; INCREASED APPETITE; INSOMNIA; LEUKOPENIA; LIBIDO DISORDER; LIVER TOXICITY; MALAISE; MOTOR COORDINATION; MUSCLE HYPERTONIA; MUSCLE HYPOTONIA; MUSCLE RIGIDITY; MYOCLONUS; NAUSEA; NERVOUSNESS; NEUROLEPTIC MALIGNANT SYNDROME; OCULOGYRIC CRISIS; OLIGURIA; ORGASM DISORDER; PAIN; PARANOIA; PARESTHESIA; PERSONALITY DISORDER; PHARMACOEPIDEMIOLOGY; PHARYNGITIS; PSYCHIATRIST; RASCH ANALYSIS; RASH; RATING SCALE; RELIABILITY; RHINITIS; SCHIZOPHRENIA; SIDE EFFECT; SOMNOLENCE; SPEECH DISORDER; STATISTICAL ANALYSIS; SUICIDE ATTEMPT; SWEATING; SYNCOPE; TACHYCARDIA; TARDIVE DYSKINESIA; THIRST; THOUGHT DISORDER; TIC; TREMOR; URINARY FREQUENCY; URINARY TRACT INFECTION; URINE RETENTION; VALIDATION PROCESS; VASODILATATION; VERTIGO; VISUAL IMPAIRMENT; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; HUMANS; OBSERVER VARIATION; SAFETY; SCHIZOPHRENIA;

EID: 10044260850     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904X11484     Document Type: Conference Paper

References (21)

1. Sacristan JA, Gomez JC, Badia X, Kind P: Global index of safety (GIS). A new instrument to assess drug safety. J Clin Epidemiol 2001;54:1120-5
2. Gomez JC, Sacristan JA, Hernandez J, et al. The safety of olanzapine compared with other antipsychotic drugs: results of an observational prospective study in patients with schizophrenia (EFESO Study). Pharmacoepidemiologic study of olanzapine in schizophrenia. J Clin Psychiatry 2000;61:335-43
3. Gomez JC, Sacristan JA, Alvarez E, et al. Safety and effectiveness of olanzapine versus typical antipsychotic drugs in the treatment of inpatients with schizophrenia (EUROPA Study). J Psychopharmacol 2000;14:PG28
4. Harris DR, Lord FM. Statistical treatment of nominal numbers. Psychol Reports 1971;29:367-72
5. MacKnight C, Rockwood K. Rasch analysis of the hierarchical assessment of balance and mobility (HABAM). J Clin Epidemiol 2000;53:1242-7
6. Rasch G. Probabilistic model for some intelligence and attainment tests. Chicago: MESA Press; 1980
7. Wright BD, Stone MH. Best test design: Rasch measurement. Chicago: MESA Press; 1979
8. Wright BD, Masters GN. Rating scale analysis: Rasch measurement. Chicago: MESA Press; 1982
9. Young NL, Williams JI, Yoshida KK, Wright JG. Measurement properties of the activities scale for kids. J Clin Epidemiol 2000;53:125-37
10. Cook KF, Rabeneck L, Campbell CJ, Wray NP. Evaluation of a multidimensional measure of dyspepsia-related health for use in a randomized clinical trial. J Clin Epidemiol 1999;52:381-92
11. Raczek AE, Ware JE, Bjorner JB, et al. Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries: results from the IQOLA Project. [International Quality of Life Assessment]. J Clin Epidemiol 1998;51:1203-14
12. Prieto L, Alonso J, Ferrer M, Anto JM. Are results of the SF-36 health survey and the Nottingham Health Profile similar? A comparison in COPD patients. [Quality of Life in COPD Study Group]. J Clin Epidemiol 1997;50:463-73
13. McHorney CA, Haley SM, Ware Jr JE. Evaluation of the MOS SF-36 physical functioning scale (PF-10): II. Comparison of relative precision using Likert and Rasch scoring methods. J Clin Epidemiol 1997;50:451-61
14. Stucki G, Daltroy L, Katz JN, Johannesson M, Liang MH. Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts. J Clin Epidemiol 1996;49:711-7
15. Haley SM, McHorney CA, Ware Jr JE. Evaluation of the MOS SF-36 physical functioning scale (PF-10): I. Unidimensionality and reproducibility of the Rasch item scale. J Clin Epidemiol 1994;47:671-84
16. Messick S. Validity of psychological assessment: validation of inferences from persons' responses and performances as scientific inquiry into score meaning. Am Psychol 1995;50:741-9
17. Anastasi A, Urbina S. Psychological testing, 7th ed. Upper Saddle River (NJ): Prentice Hall; 1997
18. Wright BD, Linacre M. Reasonable mean-square fit values. Rasch Measurement Transactions 1994;8:170
19. Linacre JM. BIGSTEPS. Chicago: MESA Press; 1995
20. Bond TG, Fox CM, Applying the Rasch model: fundamental measurement in the human sciences. Mahwah (NJ): Erlbaum; 2001
21. Smith Jr EV. Evidence for the reliability of measures and validity of measure interpretation: a Rasch measurement perspective. J Appl Measurement 2001;2:281-311